News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Alligator Bioscience To Address Immunogenicity With Epibase(R)


10/10/2006 4:11:10 PM

Lund, Sweden and Ghent, Belgium - October 09, 2006 - Alligator Bioscience AB and AlgoNomics NV today announced that they have entered into a collaboration. AlgoNomics will employ its EpibaseĀ® platform to complement Alligator Bioscience in the optimization of therapeutic proteins both in their internal projects and in collaborative projects with customers. The collaboration allows Alligator to maximally reduce immunogenicity upon optimization of protein therapeutics with their proprietary ssDNA recombination technology FINDĀ®.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES